The first randomized trial to examine whether older adults with multiple sclerosis (MS) can safely discontinue disease-modifying therapy (DMT) after years of being relapse-free failed to deliver a definitive conclusion.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045